Stay updated with breaking news from Drugs Controller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India is in regular contact with the national drug regulator of Uzbekistan regarding reports of Noida-based cough syrups allegedly linked to the deaths of 18 children in Uzbekistan, said the Union Minister of Health and Family Welfare on Thursday.
NEW DELHI: The Union Health Ministry on Thursday responded over the death of 18 children from Uzbekistan allegedly after consuming cough syrup manufactured by an Indian drug manufacturer. There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, NOIDA, Uttar Pradesh. The samples of the cough syrup have been
Neither CDSCO nor the Union health ministry under Mansukh Mandaviya have spoken on the nature of violations that were found during inspection, which led to the decision to halt production at the Noida unit.
The company's legal representative had said on Thursday that the manufacture of Dok-1 Max has stopped 'for now'
All manufacturing activities at Marion Biotech's Noida unit have been stopped in view of reports of contamination of its cough syrup, Dok-1 Max.